<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-W2FPGTTA/5bb740bad355c84-3-1a2d-4a861250a-648/PDF"><dcterms:extent>264 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-W2FPGTTA/bb285424-da73-46c1-a45b-3556a1a88d00/TEXT"><dcterms:extent>21 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2022-2025"><edm:begin xml:lang="en">2022</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-W2FPGTTA"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-UCB4A42Q" /><dcterms:issued>2023</dcterms:issued><dc:creator>Trop, Špela</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">str. 30-33</dc:format><dc:identifier>COBISSID_HOST:166098691</dc:identifier><dc:identifier>ISSN:2820-5006</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-W2FPGTTA</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Fakulteta za farmacijo, ŠSSFD</dc:publisher><dcterms:isPartOf xml:lang="sl">Placebo</dcterms:isPartOf><dc:subject xml:lang="sl">imunoterapija</dc:subject><dc:subject xml:lang="sl">Metabolizem</dc:subject><dc:subject xml:lang="sl">mRNA</dc:subject><dc:subject xml:lang="sl">Rak (medicina)</dc:subject><dc:subject xml:lang="sl">STAT3</dc:subject><dc:subject xml:lang="sl">Zdravljenje</dc:subject><dcterms:temporal rdf:resource="2022-2025" /><dc:title xml:lang="sl">Iskanje novih terapevtskih tarč za zdravljenje raka|</dc:title><dc:description xml:lang="sl">In recent years, the number of cancer patients has been increasing, which calls for new approaches to treatment. One of the effective therapeutic options is immunotherapy, which relies on activating the individual's immune system to enable an attack on cancer cells. In this article, we are highlighting the STAT3 protein as a newer target of immunotherapy, along with the use of mRNA molecules. Additionally, the search for new compounds also focuses on the energy metabolism of cancer cells, as it presents several opportunities for developing effective anti-tumor drugs. We focused on three important aspects of cancer cell metabolism that can be targeted for inhibition. The discovery of new targets in cancer therapy raises hope for more effective treatment of patients and reducing the burden of their diseases</dc:description><dc:description xml:lang="sl">V zadnjih letih se število bolnikov z rakom povečuje, kar zahteva nove pristope k zdravljenju. Ena izmed učinkovitih terapevtskih možnosti je imunska terapija, ki temelji na aktivaciji imunskega sistema posameznika, kar omogoča napad na rakave celice. Kot novejšo tarčo imunske terapije v članku izpostavljamo protein STAT3 in uporabo molekule mRNA. Poleg tega pa se iskanje novih učinkovin usmerja tudi v energijski metabolizem rakavih celic, saj ta odpira kar nekaj priložnosti za razvoj učinkovitih protitumorskih zdravil. V prispevku smo se osredotočili na tri pomembne dele metabolizma rakavih celic, ki jih lahko zaviramo. Z odkrivanjem novih tarč v terapiji raka se povečuje upanje za učinkovitejše zdravljenje pacientov in zmanjševanje bremena njihovih bolezni</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-W2FPGTTA"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-W2FPGTTA" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-W2FPGTTA/5bb740bad355c84-3-1a2d-4a861250a-648/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:dataProvider xml:lang="en">National and University Library of Slovenia</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-W2FPGTTA/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-W2FPGTTA" /></ore:Aggregation></rdf:RDF>